Thrombo-inflammation in long COVID–the elusive key to post-infection sequelae?
Long COVID is a public health emergency affecting millions of people worldwide,
characterized by heterogenous symptoms across multiple organs systems. Here, we discuss …
characterized by heterogenous symptoms across multiple organs systems. Here, we discuss …
COVID–19-associated coagulopathy: An exploration of mechanisms
ME Colling, Y Kanthi - Vascular Medicine, 2020 - journals.sagepub.com
An ongoing global pandemic of viral pneumonia (coronavirus disease [COVID-19]), due to
the virus SARS-CoV-2, has infected millions of people and remains a threat to many more …
the virus SARS-CoV-2, has infected millions of people and remains a threat to many more …
Pathophysiological mechanisms of thrombosis in acute and long COVID-19
H Jing, X Wu, M Xiang, L Liu, VA Novakovic… - Frontiers in …, 2022 - frontiersin.org
COVID-19 patients have a high incidence of thrombosis, and thromboembolic complications
are associated with severe COVID-19 and high mortality. COVID-19 disease is associated …
are associated with severe COVID-19 and high mortality. COVID-19 disease is associated …
Systemic inflammation in COVID‐19 patients may induce various types of venous and arterial thrombosis: a systematic review
S Tomerak, S Khan, M Almasri… - Scandinavian …, 2021 - Wiley Online Library
COVID‐19 is a global pandemic with a daily increasing number of affected individuals.
Thrombosis is a severe complication of COVID‐19 that leads to a worse clinical course with …
Thrombosis is a severe complication of COVID‐19 that leads to a worse clinical course with …
Hyperthrombotic milieu in COVID-19 patients
MH Kamel, W Yin, C Zavaro, JM Francis, VC Chitalia - Cells, 2020 - mdpi.com
COVID-19 infection has protean systemic manifestations. Experience from previous
coronavirus outbreaks, including the current SARS-CoV-2, has shown an augmented risk of …
coronavirus outbreaks, including the current SARS-CoV-2, has shown an augmented risk of …
Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy
Background: Severe acute respiratory syndrome corona virus 2 infection causes severe
pneumonia (coronavirus disease 2019 [COVID-19]), but the mechanisms of subsequent …
pneumonia (coronavirus disease 2019 [COVID-19]), but the mechanisms of subsequent …
The emerging threat of (micro) thrombosis in COVID-19 and its therapeutic implications
JD McFadyen, H Stevens, K Peter - Circulation research, 2020 - Am Heart Assoc
The recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
and the ensuing global pandemic has presented a health emergency of unprecedented …
and the ensuing global pandemic has presented a health emergency of unprecedented …
Pathogenic basis of thromboinflammation and endothelial injury in COVID-19: current findings and therapeutic implications
Y Higashikuni, W Liu, T Obana, M Sata - International Journal of …, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has become a global pandemic with a great impact on social …
coronavirus 2 (SARS-CoV-2), has become a global pandemic with a great impact on social …
Coagulopathy and thrombosis as a result of severe COVID-19 infection: a microvascular focus
UK Katneni, A Alexaki, RC Hunt… - Thrombosis and …, 2020 - thieme-connect.com
Coronavirus disease of 2019 (COVID-19) is the clinical manifestation of the respiratory
infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While …
infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While …
Prothrombotic phenotype in COVID-19: focus on platelets
COVID-19 infection is associated with a broad spectrum of presentations, but alveolar
capillary microthrombi have been described as a common finding in COVID-19 patients …
capillary microthrombi have been described as a common finding in COVID-19 patients …